Advertisement
Loading...

Castle Biosciences, Inc.

CSTL•NASDAQ
Healthcare
Medical - Diagnostics & Research
$19.13
$0.25(1.32%)
U.S. Market opens in 37h 19m

Castle Biosciences, Inc. (CSTL) Stock Overview

Explore Castle Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap580.2M
P/E Ratio-44.40
EPS (TTM)$-0.42
ROE-0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$24.75
3 Months$33.03
1 Year Target$32.95

CSTL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Castle Biosciences, Inc. (CSTL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 33.41, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $32.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -44.40 and a market capitalization of 580.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.32%
5-Day Change
-0.67%
1-Month Change
-22.30%
3-Month Change
-42.29%
6-Month Change
-42.81%
Year-to-Date (YTD) Change
-50.82%
1-Year Change
16.08%
3-Year Change
-18.80%
5-Year Change
-65.74%
All-Time (Max) Change
-10.61%

Contact Information

https://castlebiosciences.com
866 788 9007
505 South Friendswood Drive, Friendswood, TX, 77546

Company Facts

784 Employees
IPO DateJul 25, 2019
CountryUS
Actively Trading

Frequently Asked Questions